Stock Events

Stock Events

NovoCure 

€10.37
0
+€0.85+8.91% Wednesday 19:47

Statistics

Day High
10.37
Day Low
10.37
52W High
17.08
52W Low
8.36
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

30AprExpected
Q4 2025
Next
-0.43
-0.35
-0.27
-0.19
Expected EPS
-0.4337703234
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 038.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zimmer Biomet
ZBH
Mkt Cap18.22B
Zimmer Biomet Holdings, Inc. provides medical devices in orthopedics, a different approach but still in the competitive landscape of comprehensive cancer care solutions.
Intuitive Surgical
ISRG
Mkt Cap160.05B
Intuitive Surgical, Inc. offers robotic-assisted surgical systems, indirectly competing with NovoCure by providing alternative cancer treatment methods.
Medtronic
MDT
Mkt Cap111.97B
Medtronic plc offers medical technologies, services, and solutions, including cancer treatments, competing in the broader oncology market.
Boston Scientific
BSX
Mkt Cap91.83B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, including oncology.
Stryker
SYK
Mkt Cap129.89B
Stryker Corporation specializes in medical technologies, including surgical equipment and neurotechnology products that can be used in cancer treatments.
Abbvie
ABBV
Mkt Cap367.8B
AbbVie Inc. is a research-based biopharmaceutical company with a strong portfolio in oncology, directly competing in the cancer treatment market.
Merck
MRK
Mkt Cap300.2B
Merck & Co., Inc. is known for its pharmaceutical products for treating cancer, making it a competitor in the oncology sector.
Pfizer
PFE
Mkt Cap153.13B
Pfizer Inc. is a global biopharmaceutical company with a broad range of oncology treatments, competing in the cancer care market.
Johnson & Johnson
JNJ
Mkt Cap574.66B
Johnson & Johnson engages in the research and development, manufacture, and sale of a broad range of products in the health care field, including cancer treatments.

About

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
Show more...
CEO
Mr. William F. Doyle
Employees
1605
Country
United Kingdom
ISIN
JE00BYSS4X48

Listings

F
DE
038.F
MX
MX
NVCRN.MX
MU
DE
038.MU
STU
DE
038.STU

0 Comments

Share your thoughts

FAQ

What is NovoCure stock price today?▼
The current price of 038.STU is €10.37 EUR — it has increased by +8.91% in the past 24 hours. Watch NovoCure stock price performance more closely on the chart.
What is NovoCure stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange NovoCure stocks are traded under the ticker 038.STU.
Is NovoCure stock price growing?▼
038.STU stock has risen by +11.24% compared to the previous week, the month change is a -3.22% fall, over the last year NovoCure has showed a -24.58% decrease.
When is the next NovoCure earnings date?▼
NovoCure is going to release the next earnings report on April 30, 2026.
What were NovoCure earnings last quarter?▼
038.STU earnings for the last quarter are -0.19 EUR per share, whereas the estimation was -0.35 EUR resulting in a +46.53% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does NovoCure have?▼
As of April 16, 2026, the company has 1,605 employees.
In which sector is NovoCure located?▼
NovoCure operates in the Other sector.
When did NovoCure complete a stock split?▼
NovoCure has not had any recent stock splits.
Where is NovoCure headquartered?▼
NovoCure is headquartered in Baar, United Kingdom.